Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United Kingdom, in Belgium, in Germany, .... It focuses on ADHD.
In United Kingdom
This study is completed in France, in the United Kingdom, in Germany, .... It is testing Extended-release Guanfacine Hydrochloride for ADHD.
In United KingdomThis study was terminated in the United Kingdom, in Spain, and in Denmark. It is testing SAGE-217 WITH FIXED, REPEATED TREATMENT REGIMEN ON RELAPSE PREVENTION for depression.
In United KingdomThis study is completed in France, in the United Kingdom, in Belgium, .... It focuses on ADHD.
In United KingdomThis study is ongoing in the United Kingdom, in Belgium, in Germany, .... It focuses on ADHD.
In United KingdomThis study is completed in the United Kingdom, in Belgium, in the Netherlands, .... It is testing lisdexamfetamine Dimesylate for ADHD.
In United KingdomThis study is ongoing in the United Kingdom. It is testing efficacy, safety, and tolerability of orally administered BI 409306 during a 52-week treatment period for Schizophrenia.
In United KingdomThis study is ongoing in the United Kingdom. It focuses on Schizophrenia.
In United KingdomThis study is completed in the United Kingdom. It focuses on Addiction.
In United KingdomThis study was terminated in the United Kingdom. It focuses on Addiction.
In United KingdomThis study is completed in France, in the United Kingdom, in Belgium, .... It focuses on ADHD.
In United KingdomThis study is completed in France, in the United Kingdom, in Belgium, .... It is testing Lisdexamfetamine Dimesylate (LDX) for ADHD.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.